161 related articles for article (PubMed ID: 17517510)
1. Synthesis and evaluation of homo-bivalent GnRHR ligands.
Bonger KM; van den Berg RJ; Heitman LH; IJzerman AP; Oosterom J; Timmers CM; Overkleeft HS; van der Marel GA
Bioorg Med Chem; 2007 Jul; 15(14):4841-56. PubMed ID: 17517510
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of homodimeric GnRHR antagonists having a rigid bis-propargylated benzene core.
Bonger KM; van den Berg RJ; Knijnenburg AD; Heitman LH; Ijzerman AP; Oosterom J; Timmers CM; Overkleeft HS; van der Marel GA
Bioorg Med Chem; 2008 Apr; 16(7):3744-58. PubMed ID: 18282756
[TBL] [Abstract][Full Text] [Related]
3. Differential impact of intracellular carboxyl terminal domains on lipid raft localization of the murine gonadotropin-releasing hormone receptor.
Navratil AM; Farmerie TA; Bogerd J; Nett TM; Clay CM
Biol Reprod; 2006 May; 74(5):788-97. PubMed ID: 16371589
[TBL] [Abstract][Full Text] [Related]
4. Identification of new gonadotrophin-releasing hormone partial agonists.
Leaños-Miranda A; Ulloa-Aguirre A; Cervini LA; Janovick JA; Rivier J; Conn PM
J Endocrinol; 2006 Jun; 189(3):509-17. PubMed ID: 16731782
[TBL] [Abstract][Full Text] [Related]
5. Amiloride derivatives and a nonpeptidic antagonist bind at two distinct allosteric sites in the human gonadotropin-releasing hormone receptor.
Heitman LH; Ye K; Oosterom J; Ijzerman AP
Mol Pharmacol; 2008 Jun; 73(6):1808-15. PubMed ID: 18344315
[TBL] [Abstract][Full Text] [Related]
6. Extracellular loop 3 (EL3) and EL3-proximal transmembrane helix 7 of the mammalian type I and type II gonadotropin-releasing hormone (GnRH) receptors determine differential ligand selectivity to GnRH-I and GnRH-II.
Li JH; Choe H; Wang AF; Maiti K; Wang C; Salam A; Chun SY; Lee WK; Kim K; Kwon HB; Seong JY
Mol Pharmacol; 2005 Apr; 67(4):1099-110. PubMed ID: 15635044
[TBL] [Abstract][Full Text] [Related]
7. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo.
Conn PM; Ulloa-Aguirre A; Ito J; Janovick JA
Pharmacol Rev; 2007 Sep; 59(3):225-50. PubMed ID: 17878512
[TBL] [Abstract][Full Text] [Related]
8. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the human gonadotropin-releasing hormone receptor: insights into receptor biology and function.
Bédécarrats GY; Kaiser UB
Semin Reprod Med; 2007 Sep; 25(5):368-78. PubMed ID: 17710733
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relations of successful pharmacologic chaperones for rescue of naturally occurring and manufactured mutants of the gonadotropin-releasing hormone receptor.
Janovick JA; Goulet M; Bush E; Greer J; Wettlaufer DG; Conn PM
J Pharmacol Exp Ther; 2003 May; 305(2):608-14. PubMed ID: 12606630
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of specific probes for human 5-HT4 receptor dimerization studies.
Soulier JL; Russo O; Giner M; Rivail L; Berthouze M; Ongeri S; Maigret B; Fischmeister R; Lezoualc'h F; Sicsic S; Berque-Bestel I
J Med Chem; 2005 Oct; 48(20):6220-8. PubMed ID: 16190749
[TBL] [Abstract][Full Text] [Related]
12. Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor.
Naor Z
Front Neuroendocrinol; 2009 Jan; 30(1):10-29. PubMed ID: 18708085
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of dimeric follicle-stimulating hormone receptor antagonists.
Bonger KM; Hoogendoorn S; van Koppen CJ; Timmers CM; Overkleeft HS; van der Marel GA
ChemMedChem; 2009 Dec; 4(12):2098-102. PubMed ID: 19902448
[TBL] [Abstract][Full Text] [Related]
14. Challenges and opportunities of trapping ligands.
Szkudlinski MW
Mol Pharmacol; 2007 Aug; 72(2):231-4. PubMed ID: 17522183
[TBL] [Abstract][Full Text] [Related]
15. Calnexin regulated gonadotropin-releasing hormone receptor plasma membrane expression.
Brothers SP; Janovick JA; Conn PM
J Mol Endocrinol; 2006 Dec; 37(3):479-88. PubMed ID: 17170088
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule vasopressin-2 receptor antagonist identified by a g-protein coupled receptor "pathway" screen.
Yangthara B; Mills A; Chatsudthipong V; Tradtrantip L; Verkman AS
Mol Pharmacol; 2007 Jul; 72(1):86-94. PubMed ID: 17435162
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure-activity relationships and insurmountable antagonism.
Sullivan SK; Hoare SR; Fleck BA; Zhu YF; Heise CE; Struthers RS; Crowe PD
Biochem Pharmacol; 2006 Sep; 72(7):838-49. PubMed ID: 16930559
[TBL] [Abstract][Full Text] [Related]
18. Chimeric GnRH-LH receptors and LH receptors lacking C-terminus palmitoylation sites do not localize to plasma membrane rafts.
Lei Y; Hagen GM; Smith SM; Barisas BG; Roess DA
Biochem Biophys Res Commun; 2005 Nov; 337(2):430-4. PubMed ID: 16202972
[TBL] [Abstract][Full Text] [Related]
19. Trapping of a nonpeptide ligand by the extracellular domains of the gonadotropin-releasing hormone receptor results in insurmountable antagonism.
Kohout TA; Xie Q; Reijmers S; Finn KJ; Guo Z; Zhu YF; Struthers RS
Mol Pharmacol; 2007 Aug; 72(2):238-47. PubMed ID: 17409285
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of bivalent beta2-adrenergic and adenosine A1 receptor ligands.
Karellas P; McNaughton M; Baker SP; Scammells PJ
J Med Chem; 2008 Oct; 51(19):6128-37. PubMed ID: 18783211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
